Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionTrexquant Investment LP
Latest Disclosed Ownership218,010 shares
Latest Disclosed Value $ 12,287,044
Trexquant Investment LP reports 73.68% increase in ownership of HAE / Haemonetics Corporation

On May 15, 2026 - Trexquant Investment LP filed a 13F-HR form disclosing ownership of 218,010 shares of Haemonetics Corporation (US:HAE) valued at $12,287,044 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 125,524 shares of Haemonetics Corporation. This represents a change in shares of 73.68% during the quarter. The current value of the position is $15,539,753 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 218,010 92,486 73.68 12,287 22.14 0.0883
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 125,524 15,879 14.48 10,061 88.25 0.0897
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 109,645 59,568 118.95 5,344 43.04 0.0550
2025-08-12 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 50,077 50,077 3,736 0.0421
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -14,258 -100.00 0 -100.00
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 14,258 -29,949 -67.75 1,214 -66.84 0.0318
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 44,207 -20,894 -32.09 3,658 -28.55 0.1005
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 65,101 50,705 352.22 5,120 380.30 0.1452
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 14,396 -112,043 -88.61 1,066 -87.06 0.0375
2022-08-11 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 126,439 123,026 3,604.63 8,241 3,715.28 0.3693
2022-05-13 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 3,413 -4,456 -56.63 216 -48.20 0.0101
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 7,869 7,869 417 0.0258
2021-05-13 2021-03-31 13F HAEMONETICS COM 405024100 0 -2,928 -100.00 0 -100.00
2021-02-11 2020-12-31 13F HAEMONETICS COM 405024100 2,928 -1,929 -39.72 348 -17.92 0.0369
2020-11-06 2020-09-30 13F HAEMONETICS COM 405024100 4,857 4,857 424 0.0273
2020-05-08 2020-03-31 13F HAEMONETICS COM 405024100 0 -6,417 -100.00 0 -100.00
2020-02-12 2019-12-31 13F HAEMONETICS COM 405024100 6,417 -1,109 -14.74 737 -22.34 0.0436
2020-02-18 2019-09-30 13F/A-1 HAEMONETICS COM 405024100 7,526 7,526 949 0.0820
2019-11-08 2019-09-30 13F HAEMONETICS COM 405024100 7,526 7,526 949 81,962.6824
2019-08-09 2019-06-30 13F HAEMONETICS COM 405024100 0 -12,093 -100.00 0 -100.00
2019-05-13 2019-03-31 13F HAEMONETICS COM 405024100 12,093 12,093 1,058 0.0751
2019-02-13 2018-12-31 13F HAEMONETICS COM 405024100 0 -2,080 -100.00 0 -100.00
2018-11-09 2018-09-30 13F HAEMONETICS COM 405024100 2,080 -34,285 -94.28 238 -92.70 0.0179
2018-08-07 2018-06-30 13F HAEMONETICS COM 405024100 36,365 17,756 95.42 3,261 139.60 0.2260
2018-05-03 2018-03-31 13F HAEMONETICS COM 405024100 18,609 18,609 1,361 0.0949
2018-02-08 2017-12-31 13F HAEMONETICS COM 405024100 0 -10,302 -100.00 0 -100.00
2017-11-09 2017-09-30 13F HAEMONETICS COM 405024100 10,302 10,302 462 0.1164
2017-05-08 2017-03-31 13F HAEMONETICS COM 405024100 0 -6,682 -100.00 0 -100.00
2017-02-10 2016-12-31 13F HAEMONETICS COM 405024100 6,682 6,682 269 0.0426
2016-11-10 2016-09-30 13F HAEMONETICS COM 405024100 0 -12,445 -100.00 0 -100.00
2016-08-10 2016-06-30 13F HAEMONETICS COM 405024100 12,445 12,445 0.00 361 0.0474
2016-05-11 2016-03-31 13F HAEMONETICS COM 405024100 0 0 0 0.0000
2016-02-10 2015-12-31 13F HAEMONETICS COM 405024100 0 -12,100 -100.00 0 -100.00
2015-11-02 2015-09-30 13F HAEMONETICS COM 405024100 12,100 12,100 391 0.0337
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.